[1]
2024. The Association between Immune-Histochemical Expressions of Program death ligand with Some Aggressive Features of Prostate Cancer. Al-Nahrain Journal of Science. 27, 2 (Jun. 2024), 63–67. DOI:https://doi.org/10.22401/g18c0m59.